Tag: focal therapy

After focal therapy for prostate cancer, annual PSA testing and mpMRI scans work together to spot new cancer activity. This approach offers a balance of cancer control and quality of life, keeping future treatment options open for patients and their doctors. keep reading

Artificial Intelligence is reshaping prostate cancer care, from more accurate screening and early detection to optimizing treatment strategies. New research highlights four major clinical areas where AI is already making a measurable difference in diagnosis, risk assessment, and therapy planning. keep reading

Focal therapy methods for prostate cancer, such as Focal Laser Ablation and TULSA, show promise in preserving sexual function while maintaining cancer control. New research highlights a better balance between treatment effectiveness and quality of life for men facing low- to intermediate-risk prostate cancer. keep reading

Focal therapy matches radical prostatectomy in prostate cancer control while offering fewer side effects and preserving treatment choices if cancer returns. Evidence supports its effectiveness for men with localized disease. keep reading

Experts outline a 10-step process that enhances the accuracy of focal therapy for prostate cancer, using detailed MRI imaging, calculated safety margins, and thoughtful selection of treatment methods. The framework aims to maximize tumor control while minimizing side effects. keep reading

Can a cancer diagnosis bring a sense of relief? For men with prostate cancer caught at Grade Group 1, emerging research and expert protocols suggest that aggressive treatments can often be avoided. Active surveillance, targeted focal therapies, and more precise diagnostic tools are helping many choose paths that spare quality of life. keep reading

What if treating prostate cancer didn’t have to mean sacrificing the whole gland? Thanks to advances in multiparametric MRI and MRI-targeted biopsy, focal therapy can pinpoint and erase tumors with a margin of safety while sparing healthy tissue. Lower side effect rates and preserved function set this approach apart. keep reading

Choosing the right prostate cancer treatment goes beyond medical statistics—it's about aligning therapy with individual lifestyles, priorities, and long-term well-being. Shared decision-making, patient-reported outcomes, and emerging therapies offer hope for better cancer control with fewer side effects. keep reading

UPDATE: 11/21/2025 Originally published Mar. 11, 2024 The blog below announced news that before radical prostatectomy (RP), multiparametric MRI findings can predict if a prostate cancer (PCa) patient is at risk of recurrence after RP. Prior to MRI predictions, the CAPRA-S score had become the gold standard for predicting biochemical recurrence risk—but only after the surgery was done. Thus, keep reading